Aakaar Medical Technologies IPO Live
Already have an account? Apply now
Schedule of Aakaar Medical Technologies
| Issue open date | 20 Jun 2025 |
| Issue close date | 24 Jun 2025 |
| UPI mandate deadline | 24 Jun 2025 (5 PM) |
| Allotment finalization | 25 Jun 2025 |
| Refund initiation | 26 Jun 2025 |
| Share credit | 26 Jun 2025 |
| Listing date | 27 Jun 2025 |
| Mandate end date | 29 Jun 2025 |
| Lock-in end date for anchor investors (50%) | 25 Jul 2025 |
| Lock-in end date for anchor investors (remaining) | 23 Sep 2025 |
Note: The schedule is tentative. The anchor lock-in period ends 30 days after the actual allotment date for 50% of the shares and 90 days after for the remaining portion. The allotment status can be checked on the registrar's website and the exchange website.
About Aakaar Medical Technologies
Founded in 2013 under the leadership of Mr. Dilip Meswani, Aakaar Medical Technologies is an aesthetic medical company specializing in cosmetic products and devices. The company operates a comprehensive B2B distribution network, serving dermatologists, plastic surgeons, and aesthetic physicians across 15 Indian states through 90 trained sales and service engineers. Aakaar’s diverse portfolio includes both proprietary domestically-manufactured products and premium imported brands from South Korea, Spain, Italy, and Austria, covering skincare, hair care, injectable treatments, and advanced aesthetic devices. With over 25 years of industry expertise, the company has established a strong market presence serving thousands of satisfied customers.
Financials of Aakaar Medical Technologies
Issue size
| Funds Raised in the IPO | Amount |
| Overall | ₹27 crores |
| Fresh Issue | ₹27 crores |
Utilisation of proceeds
| Purpose | INR crores (%) |
| Working capital requirements | 20.35 (75.37%) |
| General corporate purposes | – |
Strengths
- Experienced Management & Leadership Team
- Diversified Customer Base
- Diversified Product Base
- Pan India reach through our Consignment Sales partner.
Risks
- Heavy reliance on imported third-party manufactured brands
- Exposure to raw material and transportation cost volatility
- Geographic concentration in Maharashtra and Karnataka states
- Dependency on third-party agent for storage and distribution
- Operational risk from CSA agreement non-performance